Isofol Medical Valuation
| ISOFOL Stock | SEK 2.23 0.29 11.51% |
Based on Macroaxis valuation methodology, the firm appears to be fairly valued. Isofol Medical AB retains a regular Real Value of kr2.14 per share. The prevalent price of the firm is kr2.23. Our model calculates the value of Isofol Medical AB from evaluating the firm fundamentals such as Return On Equity of -0.69, return on asset of -0.36, and Shares Outstanding of 161.52 M as well as inspecting its technical indicators and probability of bankruptcy.
Fairly Valued
Today
Please note that Isofol Medical's price fluctuation is dangerous at this time. Calculation of the real value of Isofol Medical AB is based on 3 months time horizon. Increasing Isofol Medical's time horizon generally increases the accuracy of value calculation and significantly improves the predictive power of the methodology used.
Since Isofol Medical is currently traded on the exchange, buyers and sellers on that exchange determine the market value of Isofol Stock. However, Isofol Medical's intrinsic value may or may not be the same as its current market price, in which case there is an opportunity to profit from the mispricing, assuming the market price will eventually merge with its intrinsic value. | Historical | Market 2.23 | Real 2.14 | Hype 2.23 | Naive 2.17 |
The real value of Isofol Stock, also known as its intrinsic value, is the underlying worth of Isofol Medical AB Company, which is reflected in its stock price. It is based on Isofol Medical's financial performance, growth prospects, management team, or industry conditions. The intrinsic value of Isofol Medical's stock can be calculated using various methods such as discounted cash flow analysis, price-to-earnings ratio, or price-to-book ratio. That value may differ from its current market price, which is determined by supply and demand factors such as investor sentiment, market trends, or news.
Estimating the potential upside or downside of Isofol Medical AB helps investors to forecast how Isofol stock's addition to their portfolios will impact the overall performance. We also use other valuation drivers to help us estimate the true value of Isofol Medical more accurately as focusing exclusively on Isofol Medical's fundamentals will not take into account other important factors: Isofol Medical Total Value Analysis
Isofol Medical AB is currently estimated to have takeover price of (42.41 M) with market capitalization of 109.18 M, debt of 110 K, and cash on hands of 379.45 M. The negative valuation of Isofol Medical may imply that the market is not capable to price the future growth of the company or it is pricing it at zero value. It may also suggest that takeover valuation may not have captured all of the outstanding financial obligations of the company both on and off balance sheet. Investors should thoroughly investigate all of the Isofol Medical fundamentals.| Takeover Price | Market Cap | Debt Obligations | Cash |
(42.41 M) | 109.18 M | 110 K | 379.45 M |
Isofol Medical Investor Information
About 26.0% of the company shares are held by company insiders. The company has price-to-book (P/B) ratio of 0.65. Some equities with similar Price to Book (P/B) outperform the market in the long run. Isofol Medical AB recorded a loss per share of 1.42. The entity had not issued any dividends in recent years. Isofol Medical AB is not in a good financial situation at the moment. It has a very high risk of going through financial straits in January.Isofol Medical Asset Utilization
The asset utilization indicator refers to the revenue earned for every dollar of assets a company currently reports. Isofol Medical has an asset utilization ratio of 5.58 percent. This suggests that the Company is making kr0.0558 for each dollar of assets. An increasing asset utilization means that Isofol Medical AB is more efficient with each dollar of assets it utilizes for everyday operations.Isofol Medical Ownership Allocation
Isofol Medical AB has a total of 161.52 Million outstanding shares. Isofol Medical secures significant amount of outstanding shares owned by insiders. An insider is usually defined as a CEO, other corporate executive, director, or institutional investor who own at least 10% of the company's outstanding shares. Since such a large part of the company is owned by insiders, it is advisable to analyze if each of these insiders have been buying or selling the stock in recent months. Please note that no matter how many assets the company holds, if the real value of the firm is less than the current market value, you may not be able to make money on it.Isofol Medical Profitability Analysis
The company reported the revenue of 22.41 M. Net Loss for the year was (200.25 M) with loss before overhead, payroll, taxes, and interest of (174.31 M).Please note that valuation analysis is one of the essential comprehensive assessments in business. It evaluates Isofol Medical's worth, which you can determine by considering its current assets, liabilities and future cash flows. The investors' valuation analysis is an important metric that will give you a perspective on different companies. It helps you know the worth of the potential investment in Isofol Medical and how it compares across the competition.
About Isofol Medical Valuation
The stock valuation mechanism determines Isofol Medical's current worth on a weekly basis. Our valuation model uses a comparative analysis of Isofol Medical. We calculate exposure to Isofol Medical's market risk, different technical and fundamental indicators, and relevant financial multiples and ratios and then compare them to those of Isofol Medical's related companies.Isofol Medical AB , a clinical stage biotech company, develops, commercializes, and sells oncology drugs in Sweden and internationally. The company was incorporated in 2008 and is headquartered in Gothenburg, Sweden. Isofol Medical operates under Biotechnology classification in Sweden and is traded on Stockholm Stock Exchange. It employs 12 people.
8 Steps to conduct Isofol Medical's Valuation Analysis
Company's valuation is the process of determining the worth of any company in monetary terms. It estimates Isofol Medical's potential worth based on factors such as financial performance, market conditions, growth prospects, and overall economic environment. The result of company valuation is a single number representing a Company's current market value. This value can be used as a benchmark for various financial transactions such as mergers and acquisitions, initial public offerings (IPOs), or private equity investments. To conduct Isofol Medical's valuation analysis, follow these 8 steps:- Gather financial information: Obtain Isofol Medical's financial statements, including balance sheets, income statements, and cash flow statements.
- Determine Isofol Medical's revenue streams: Identify Isofol Medical's primary sources of revenue, including products or services offered, target markets, and pricing strategies.
- Analyze market data: Research Isofol Medical's industry and market trends, including the size of the market, growth rate, and competition.
- Establish Isofol Medical's growth potential: Evaluate Isofol Medical's management, business model, and growth potential.
- Determine Isofol Medical's financial performance: Analyze its financial statements to assess its historical performance and future potential.
- Choose a valuation method: Consider the Company's specific circumstances and choose an appropriate valuation method, such as the discounted cash flow (DCF) or comparable analysis method.
- Calculate the value: Apply the chosen valuation method to the financial information and market data to calculate Isofol Medical's estimated value.
- Review and adjust: Review the results and make necessary adjustments, considering any relevant factors that may have been missed or overlooked.
Complementary Tools for Isofol Stock analysis
When running Isofol Medical's price analysis, check to measure Isofol Medical's market volatility, profitability, liquidity, solvency, efficiency, growth potential, financial leverage, and other vital indicators. We have many different tools that can be utilized to determine how healthy Isofol Medical is operating at the current time. Most of Isofol Medical's value examination focuses on studying past and present price action to predict the probability of Isofol Medical's future price movements. You can analyze the entity against its peers and the financial market as a whole to determine factors that move Isofol Medical's price. Additionally, you may evaluate how the addition of Isofol Medical to your portfolios can decrease your overall portfolio volatility.
| CEOs Directory Screen CEOs from public companies around the world | |
| Portfolio Holdings Check your current holdings and cash postion to detemine if your portfolio needs rebalancing | |
| Analyst Advice Analyst recommendations and target price estimates broken down by several categories | |
| Portfolio Diagnostics Use generated alerts and portfolio events aggregator to diagnose current holdings |